ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152 | -16.0% | 50,510 | +4.6% | 0.01% | -12.5% |
| Q2 2023 | $181 | +123.5% | 48,280 | +99.2% | 0.01% | +100.0% |
| Q1 2023 | $81 | -22.1% | 24,241 | +12.1% | 0.00% | -33.3% |
| Q4 2022 | $104 | -99.9% | 21,624 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $123,000 | -32.0% | 21,624 | -15.1% | 0.01% | -50.0% |
| Q2 2022 | $181,000 | – | 25,456 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 1,265,631 | $27,186,000 | 91.01% |
| Yu Fan | 143,867 | $3,090,000 | 34.92% |
| AJU IB Investment Co., Ltd. | 1,745,331 | $37,490,000 | 21.62% |
| Bain Capital Life Sciences Investors, LLC | 5,615,659 | $120,624,000 | 7.90% |
| Cormorant Asset Management, LP | 6,411,355 | $137,716,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 373,288 | $8,018,000 | 1.99% |
| RA Capital Management | 5,368,451 | $115,314,000 | 1.85% |
| Omega Fund Management, LLC | 746,868 | $16,043,000 | 1.82% |
| CM Management, LLC | 90,000 | $1,933,000 | 1.40% |
| SECTORAL ASSET MANAGEMENT INC | 538,884 | $11,575,000 | 0.94% |